Skip to main content

Original Research

Clinical, Original Research
Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis
Tope Olufade, PhD, MPH; Amanda M. Kong, MPH; Nicole Princic, MS; Paul Juneau, MS; Rucha Kulkarni, MPH; Kui Zhang, MD; Catherine Datto, MD, MS
Stakeholder Perspective
The Opioid Epidemic: Healthcare Utilization and Cost Considerations
Jack E. Fincham, PhD, RPh
Read More
Clinical, Original Research
Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population
Jill R. Davis, MS; Bingcao Wu, MS; David M. Kern, PhD; Ozgur Tunceli, PhD; Kathleen M. Fox, PhD; John Horton, MS; Randall F. Legg, PharmD, MBA; Frank Trudo, MD, MBA
Stakeholder Perspective
When an Outcome Is Overdetermined: Nonadherence, Utilization, and the Impetus for Research in COPD
Michael F. Murphy, MD, PhD
Read More
Business, Original Research
Does a Free Office Visit Affect Primary Care–Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi
Bettina M. Beech, DrPH, MPH; Tristan Cordier, MPH; Laura E. Happe, PharmD, MPH; Laura Trunk, MD; Gilbert S. Haugh, MS; Richard Kwong, MPH; Vipin Gopal, PhD; Roy A. Beveridge, MD
Stakeholder Perspective
Patients’ Choice for Site of Care Motivated by More Than Cost Alone
James T. Kenney, Jr, RPh, MBA
Read More
Original Research
Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service
Stakeholder Perspective
An Ounce of Prevention Is Not a Choice a Patient Gets to Make for Late-Stage Cancer
Read More
Business, Original Research
Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors
Stakeholder Perspective
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
Read More
Clinical, Original Research
Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid Arthritis
Stakeholder Perspective
You Cannot Manage What You Cannot Measure
Read More
Business, Original Research
Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease
Stakeholder Perspective
A Teachable Moment in Health Benefits Design
Read More
Original Research
Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression
Stakeholder Perspective
Counting on a Run of Value-Based Benefit Design
Read More
Original Research
Is Response-Guided Therapy Being Applied in the Clinical Setting? The Hepatitis C Example
Stakeholder Perspective
Response-Guided Therapy an Appropriate Tool for Evaluating Treatment Protocols and Costs of Drug Therapies
Read More
Original Research
Obesity in the Workplace: Impact on Cardiovascular Disease, Cost, and Utilization of Care
Stakeholder Perspective
Employers’ Obesity Initiatives in the Workplace: A Wakeup Call for Health Plans
Read More
Page 10 of 11
Results 91 - 100 of 108